C12N 2502/25
Urinary tract cells, renal cells
C12N2502/25 (Urinary tract cells, renal cells) appears on 55 US grants and 67 published applications in this corpus.
Search patents in C12N- Granted patents
- 55
- Published applications
- 67
- Assignees
- 50
- Inventors
- 150
- Latest grant
- 21 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 4 |
| 2002 | 4 | 1 |
| 2003 | 1 | 5 |
| 2004 | 0 | 6 |
| 2005 | 5 | 5 |
| 2006 | 2 | 0 |
| 2007 | 1 | 3 |
| 2008 | 2 | 2 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 2 | 3 |
| 2012 | 3 | 2 |
| 2013 | 3 | 0 |
| 2014 | 1 | 3 |
| 2015 | 1 | 1 |
| 2016 | 1 | 4 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 5 |
| 2020 | 0 | 2 |
| 2021 | 1 | 5 |
| 2022 | 1 | 2 |
| 2023 | 3 | 2 |
| 2024 | 4 | 3 |
| 2025 | 1 | 3 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions comprising cell-delivered vesicles and uses thereof21 Oct 2025US 12,447,179 B2ProKidney
- Perfusable-type dual proximal tubule cell construct and producing method thereof for applying in vitro artificialrenal tissue model and renal cell therapy12 Mar 2024US 11,925,726 B2Postech Research and Business Development Foundation
- Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers13 Feb 2024US 11,897,935 B2Immatics Biotechnologies GmbH
- Peptides, combination of peptides as targets and for use in immunotherapy13 Feb 2024US 11,897,936 B2Immatics Biotechnologies GmbH
- Engineered renal tissues, arrays thereof, and methods of making the same9 Jan 2024US 11,867,689 B2Organovo, Inc.
- Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells6 Aug 2026US 2026/0226415 A1IntegriCulture Inc.
- Method of determining fusogenic potential of sperm and use thereof in assisted fertilization and drug screening14 May 2026US 2026/0133182 A1Technion Research & Development Foundation Limited
- Compositions comprising cell-delivered vesicles and uses thereof26 Feb 2026US 2026/0053858 A1ProKidney
- Method for culturing liver-derived cells and culture system including liver-derived cells18 Dec 2025US 2025/0382579 A1IntegriCulture Inc.
- Selective cell therapy for the treatment of renal failure15 May 2025US 2025/0154471 A1Wake Forest University Health Sciences
Most cited
By later US patents
- Preparing artificial organs by forming polylayers of different cell populations on a substrate141US 6,428,802 B1Children's Medical Center Corporation · 2002
- Method and compositions of a bioartificial kidney suitable for use in vivo or ex vivo99US 5,686,289 AUniversity of Michigan · 1997
- Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo87US 5,549,674 AThe Regents of the University of Michigan · 1996
- Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo50US 6,150,164 AThe Regents of the University of Michigan · 2000
- Enhanced growth medium and method for culturing human mammary epithelial cells46US 4,423,145 A1983